Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons

被引:28
|
作者
Das, Sucharita [1 ]
Basu, Soumalee [1 ]
机构
[1] Univ Calcutta, Dept Microbiol, 35 Ballygunge Circular Rd, Kolkata 700019, India
关键词
MTDL; Multi-factorial; Secretase; A beta aggregation; NFT; Anti-oxidant; Cholinesterase; MOA; PDE; APOE; MULTITARGET-DIRECTED LIGANDS; CHOLINESTERASE/MONOAMINE OXIDASE-INHIBITORS; H-3 RECEPTOR ANTAGONIST; SITE ACETYLCHOLINESTERASE INHIBITORS; TACRINE-COUMARIN HYBRIDS; BETA-AMYLOID AGGREGATION; DRUG DESIGN STRATEGY; BIOLOGICAL EVALUATION; 5-HT6; RECEPTOR; HISTAMINE H-3;
D O I
10.2174/1568026617666170707130652
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Alzheimer's Disease (AD) is a single major cause of dementia in middle to old age individuals involving several different etiopathological mechanisms that are yet to be properly characterized. Major invariant and characteristic features consist of the progressive cerebral deposition of the Amyloid beta-protein (A beta) and the neurofibrillary degeneration through Neurofibrillary Tangles (NFT) formed by hyperphosphorylation of the tau proteins in the regions of the brain that deal with memory and cognition. There are at least five subgroups of AD that can be identified by determining Cerebrospinal Fluid (CSF) levels of A beta(1-42), tau and ubiquitin. This multifactorial nature of the disease thus demands promising approaches for the development of rational disease-modifying drugs. A large number of agents have been discovered against individual targets but the success rate is very low and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area. A very promising modern approach solicits the design of Multi-Target-Directed Ligands (MTDLs) based on the "one molecule multiple targets" paradigm that has been specifically adopted for the treatment of disorders with complex pathological mechanisms. AD is one such disorder in which MTDL has found applicability. This review aims at providing an overview of the research carried out in discovering more efficient treatment against AD using MTDL, with a goal to ascertain safer drugs.
引用
收藏
页码:3017 / 3061
页数:45
相关论文
共 50 条
  • [21] Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease
    Penny, Lewis K.
    Lofthouse, Richard
    Arastoo, Mohammad
    Porter, Andy
    Palliyil, Soumya
    Harrington, Charles R.
    Wischik, Claude M.
    TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01):
  • [22] Alzheimer's Disease: The Pros and Cons of Pharmaceutical, Nutritional, Botanical, and Stimulatory Therapies, with a Discussion of Treatment Strategies from the Perspective of Patients and Practitioners
    Wollen, Keith A.
    ALTERNATIVE MEDICINE REVIEW, 2010, 15 (03) : 223 - 244
  • [23] Pros and Cons of Marijuana in Treatment of Parkinson's Disease
    Patel, Rikinkumar S.
    Kamil, Saher
    Shah, Mansi R.
    Bhimanadham, Narmada Neerja
    Imran, Sundus
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (06)
  • [24] Multi-Targeting Nano-Systems Targeting Heterogeneous Cancer Cells for Therapeutics and Biomarker Detection
    Ren, Xiao-He
    Han, Di
    He, Xiao-Yan
    Guo, Tao
    Chen, Xue-Si
    Pang, Xuan
    Cheng, Si-Xue
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (04)
  • [25] Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics
    Chakraborty, Sandipan
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (31) : 3336 - 3348
  • [26] Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics
    Deardorff, William James
    Grossberg, George T.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (01) : 17 - 32
  • [27] Application of quinazoline and pyrido[3,2-d]pyrimidine templates to design multi-targeting agents in Alzheimer's disease
    Mohamed, Tarek
    Mann, Mandeep K.
    Rao, Praveen P. N.
    RSC ADVANCES, 2017, 7 (36): : 22360 - 22368
  • [28] Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment
    Verma, Akash
    Waiker, Digambar Kumar
    Singh, Neha
    Singh, Abhinav
    Saraf, Poorvi
    Bhardwaj, Bhagwati
    Kumar, Pradeep
    Krishnamurthy, Sairam
    Srikrishna, Saripella
    Shrivastava, Sushant Kumar
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 271
  • [29] Macrophage Membrane-Modified MoS2 Quantum Dots as a Nanodrug for Combined Multi-Targeting of Alzheimer's Disease
    Qi, Xiating
    Li, Lianxin
    Ye, Pengkun
    Xie, Meng
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (06)
  • [30] Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies
    Dahiya, Mini
    Yadav, Monu
    Goyal, Chetan
    Kumar, Anil
    INFLAMMOPHARMACOLOGY, 2025, : 1817 - 1831